Literature DB >> 28382102

Bilateral Triple-Negative Invasive Breast Cancer with a BRCA2 Mutation, and Glioblastoma: A Case Report and Literature Review.

Ali Raufi1, Mohamed Alsharedi1, Yousef Khelfa1, Maria Tirona1.   

Abstract

Breast cancer is the second leading cause of death among women in North America. Glioblastoma is the most common primary malignant central nervous system tumor in adults. The majority of hereditary breast cancers are associated with deleterious mutations in the BRCA1 and BRCA2 genes. Although few case reports have described the incidence of glioblastoma in patients previously diagnosed with breast cancer, any association between BRCA2 mutations and glioblastoma has not been demonstrated to date. Herein, we report a woman who is a carrier of a familial BRCA2 mutation, and was previously diagnosed with triple-negative breast cancer (TNBC) and subsequently with a second primary TNBC and glioblastoma. Further investigation is required to define the possible relationship between these two aggressive malignances and the BRCA2 mutation, which might be critical for the proper management and treatment of this disease.

Entities:  

Keywords:  BRCA2 genes; Glioblastoma; Triple-negative breast neoplasms

Year:  2017        PMID: 28382102      PMCID: PMC5378570          DOI: 10.4048/jbc.2017.20.1.108

Source DB:  PubMed          Journal:  J Breast Cancer        ISSN: 1738-6756            Impact factor:   3.588


  15 in total

1.  Hormonal effects on glioblastoma multiforme in the nude rat model.

Authors:  R J Plunkett; A Lis; T A Barone; M D Fronckowiak; S J Greenberg
Journal:  J Neurosurg       Date:  1999-06       Impact factor: 5.115

2.  Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2.

Authors:  Blanche P Alter; Philip S Rosenberg; Lawrence C Brody
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

3.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

4.  Multicentric glioblastoma multiforme in a patient with BRCA-1 invasive breast cancer.

Authors:  Sarina B Elmariah; Jason Huse; Bernard Mason; Peter Leroux; Robert A Lustig
Journal:  Breast J       Date:  2006 Sep-Oct       Impact factor: 2.431

5.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

Review 6.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Genetic pathways to glioblastoma: a population-based study.

Authors:  Hiroko Ohgaki; Pierre Dessen; Benjamin Jourde; Sonja Horstmann; Tomofumi Nishikawa; Pier-Luigi Di Patre; Christoph Burkhard; Danielle Schüler; Nicole M Probst-Hensch; Paulo César Maiorka; Nathalie Baeza; Paola Pisani; Yasuhiro Yonekawa; M Gazi Yasargil; Urs M Lütolf; Paul Kleihues
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

8.  Glioblastoma multiforme and breast cancer: report on 11 cases and clinico-pathological remarks.

Authors:  Manolo Piccirilli; Maurizio Salvati; Simona Bistazzoni; Alessandro Frati; Christian Brogna; Felice Giangaspero; Riccardo Frati; Antonio Santoro
Journal:  Tumori       Date:  2005 May-Jun

9.  Demographic variation in incidence of adult glioma by subtype, United States, 1992-2007.

Authors:  Robert Dubrow; Amy S Darefsky
Journal:  BMC Cancer       Date:  2011-07-29       Impact factor: 4.430

10.  BRCA1 germline mutation and glioblastoma development: report of cases.

Authors:  Meriem Boukerroucha; Claire Josse; Karin Segers; Sonia El-Guendi; Pierre Frères; Guy Jerusalem; Vincent Bours
Journal:  BMC Cancer       Date:  2015-03-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.